BIOTECHNOLOGY VALUE FUND L P

SAN FRANCISCO, CA Hedge Fund Activist Investor How do I update this listing?

Create Email Alert

Biotechnology Value Fund L P is based out of San Francisco. Whalewisdom has at least 141 13D filings, 721 13G filings, and 42 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2022-01-04. The filing was for a pooled investment fund: hedge fund The notice included securities offered of Pooled Investment Fund Interests

Contact Info

biotechnology value fund l p
44 MONTGOMERY STREET
SAN FRANCISCO CA    94104

Business Phone: 3125066500
SEC SIC CODE:
6282-INVESTMENT ADVICE
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
Principia Biopharma Inc (PRNB1) HEALTH CARE 5,231,900 523,451,595.00 1 13D 2020-08-25
MoonLake Immunotherapeutics (MLTX) FINANCE 21,751,284 288,204,513.00 2 13D 2022-04-05
Five Prime Therapeutics Inc (FPRX) HEALTH CARE 6,338,678 240,869,764.00 3 13G 2021-03-04
CTI BioPharma Corp (CTIC) HEALTH CARE 28,463,021 177,324,620.83 4 13D 2022-08-09
GH Research PLC (GHRS) HEALTH CARE 9,275,158 169,642,639.82 5 13G 2021-12-31
Calliditas Therapeutics AB ADS (CALT) HEALTH CARE 7,431,562 142,240,096.68 6 13G 2020-11-09
Xenon Pharmaceuticals Inc (XENE) HEALTH CARE 4,305,540 131,620,357.80 7 13G 2021-12-31
Arcus Biosciences Inc (RCUS) HEALTH CARE 3,960,948 125,007,518.88 8 13G 2022-03-03
Protagonist Therapeutics Inc (PTGX) HEALTH CARE 4,891,945 115,841,257.60 9 13G 2021-12-31
Merus BV (MRUS) HEALTH CARE 4,135,071 109,331,277.24 10 13G 2021-12-31
Repare Therapeutics Inc. (RPTX) HEALTH CARE 8,141,988 103,158,987.96 11 13G 2022-06-02
Xoma Corporation (XOMA) HEALTH CARE 3,530,543 98,784,593.14 12 13D 2021-03-31
Molecular Partners AG (MOLN) HEALTH CARE 4,526,282 93,015,095.10 13 13G 2022-01-10
Syndax Pharmaceuticals Inc (SNDX) HEALTH CARE 4,931,879 85,716,057.02 14 13G 2021-12-31
Aclaris Therapeutics Inc (ACRS) HEALTH CARE 3,868,043 66,685,061.32 15 13G 2022-01-13
Crinetics Pharmaceuticals Inc (CRNX) HEALTH CARE 3,003,879 65,935,144.05 16 13G 2021-10-21
Kymera Therapeutics, Inc. (KYMR) HEALTH CARE 4,138,758 62,288,307.90 17 13D 2022-05-27
iTeos Therapeutics, Inc. (ITOS) HEALTH CARE 1,929,201 56,332,669.20 18 13G 2022-04-22
Cullinan Management Inc (CGEM) HEALTH CARE 5,369,459 56,218,235.73 19 13G 2021-12-31
Relmada Therapeutics Inc (RLMD) HEALTH CARE 1,647,400 44,463,326.00 20 13G 2021-12-09
Forward Pharma A/S ADR (FWP) HEALTH CARE 7,193,088 41,791,841.28 21 13G 2021-12-31
Viridian Therapeutics Inc (VRDN) HEALTH CARE 2,202,315 40,720,804.35 22 13G 2021-12-31
Olema Pharmaceuticals, Inc. (OLMA) HEALTH CARE 7,411,503 31,573,002.78 23 13D 2021-11-30
Lexicon Pharmaceuticals Inc (LXRX) HEALTH CARE 14,360,000 30,012,400.00 24 13G 2021-12-31
Spero Therapeutics Inc (SPRO) HEALTH CARE 3,411,520 29,680,224.00 25 13G 2021-12-31
AC Immune SA (ACIU) HEALTH CARE 7,062,379 28,249,516.00 26 13G 2021-12-31
Tyra Biosciences Inc (TYRA) HEALTH CARE 2,472,327 26,453,898.90 27 13G 2022-03-14
Verastem Inc (VSTM) HEALTH CARE 18,506,158 26,093,682.78 28 13G 2022-01-06
Sutro Biopharma Inc (STRO) HEALTH CARE 3,160,416 25,978,619.52 29 13G 2022-01-07
AN2 Therapeutics Inc (ANTX) HEALTH CARE 1,616,665 24,363,141.55 30 13G 2022-03-25
Essa Pharma Inc (EPIX) HEALTH CARE 8,748,629 23,533,812.01 31 13G 2022-07-08
Cogent Biosciences Inc (COGT) HEALTH CARE 3,114,532 23,327,844.68 32 13G 2021-12-31
4D Molecular Therapeutics, Inc. (FDMT) HEALTH CARE 4,007,413 22,762,105.84 33 13G 2022-06-16
Pieris Pharmaceuticals Inc (PIRS) HEALTH CARE 7,406,643 22,442,128.29 34 13G 2021-12-31
Centessa Pharmaceuticals PLC (CNTA) HEALTH CARE 6,894,345 21,924,017.10 35 13G 2022-06-06
Ideaya Biosciences Inc (IDYA) HEALTH CARE 1,964,859 21,004,342.71 36 13G 2022-04-22
Ovid Therapeutics Inc (OVID) HEALTH CARE 6,631,051 20,821,500.14 37 13G 2021-04-13
Rain Therapeutics Inc (RAIN) HEALTH CARE 3,526,729 17,880,516.03 38 13D 2022-01-07
Sunesis Pharmaceuticals Inc (VIRX) HEALTH CARE 3,731,744 17,763,101.44 39 13G 2021-12-31
Alpine Immune Sciences Inc (ALPN) HEALTH CARE 1,589,495 14,257,770.15 40 13G 2021-12-31
89bio, Inc. (ETNB) HEALTH CARE 3,898,000 13,448,100.00 41 13G 2022-06-29
Concert Pharmaceuticals Inc (CNCE) HEALTH CARE 3,596,757 12,121,071.09 42 13G 2021-11-03
Molecular Templates Inc (MTEM) HEALTH CARE 3,379,599 11,659,616.55 43 13G 2021-12-31
Annexon, Inc. (ANNX) HEALTH CARE 3,343,194 11,032,540.20 44 13G 2022-05-16
Ikena Oncology Inc (IKNA) HEALTH CARE 1,798,371 10,970,063.10 45 13G 2021-12-31
GlycoMimetics Inc (GLYC) HEALTH CARE 9,544,262 10,880,458.68 46 13G 2020-12-31
CytomX Therapeutics Inc (CTMX) HEALTH CARE 6,595,801 9,563,911.45 47 13G 2022-07-27
Eledon Pharmaceuticals Inc (ELDN) HEALTH CARE 2,326,710 9,167,237.40 48 13G 2022-01-20
Erytech Pharma SA ADR (ERYP) HEALTH CARE 5,119,183 8,958,570.25 49 13G 2021-12-31
Bionomics Ltd. (BNOX) HEALTH CARE 944,944 8,032,022.39 50 13G 2021-12-31
Genocea Biosciences Inc (GNCA) HEALTH CARE 5,930,353 7,412,941.25 51 13G 2021-12-31
Infinity Pharmaceuticals Inc (INFI) HEALTH CARE 6,353,645 7,243,155.30 52 13G 2021-12-31
Pyxis Oncology Inc (PYXS) HEALTH CARE 1,791,351 7,237,058.04 53 13G 2021-12-10
Cidara Therapeutics Inc (CDTX) HEALTH CARE 6,861,127 5,715,318.79 54 13G 2021-12-14
5:01 Acquisition Corp. (FVAM) FINANCE 500,000 4,925,000.00 55 13G 2020-10-14
Elevation Oncology Inc (ELEV) HEALTH CARE 1,611,698 4,061,478.96 56 13G 2021-12-31
Calithera Biosciences Inc (CALA) HEALTH CARE 372,617 3,010,741.72 57 13G 2021-07-06
Regulus Therapeutics Inc (RGLS) HEALTH CARE 966,124 2,898,370.50 58 13G 2021-12-31
Galmed Pharmaceuticals Ltd (GLMD) HEALTH CARE 1,799,694 2,861,513.46 59 13G 2020-12-31
Aileron Therapeutics Inc (ALRN) HEALTH CARE 5,265,555 2,695,964.16 60 13G 2021-01-06
ContraFect Corp (CFRX) HEALTH CARE 1,847,299 803,575.07 61 13G 2022-07-15
X4 PHARMACEUTICALS ORD SHS (XFOR) 3,027,672 62 13G 2021-12-31

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2022-01-04 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 1,106,082,682 INDEFINITE
2021-01-07 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 675,082,682 INDEFINITE
2020-01-10 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 413,832,682 INDEFINITE
2019-01-11 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 224,032,682 INDEFINITE
2017-12-08 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 224,032,682 INDEFINITE
2016-09-21 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 212,032,682 INDEFINITE
2014-11-12 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 64,755,500 INDEFINITE
2013-11-08 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 41,655,500 INDEFINITE
2012-11-08 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 37,655,500 INDEFINITE
2011-11-08 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 36,155,500 INDEFINITE
2010-10-21 D POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 34,905,500 INDEFINITE
2009-10-15 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 29,155,500 INDEFINITE
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
N/A BVF PARTNERS, L.P. subscription required
    EXECUTIVE OFFICER
N/A BVF INC. subscription required
    EXECUTIVE OFFICER
MARK N LAMPERT subscription required
    EXECUTIVE OFFICER
MATTHEW D PERRY subscription required
    EXECUTIVE OFFICER
OLEG NODELMAN subscription required
    EXECUTIVE OFFICER
MARC N. LAMPERT subscription required
    EXECUTIVE OFFICER
SPIKE LOY subscription required
    EXECUTIVE OFFICER
MITCHELL KAYE subscription required
    EXECUTIVE OFFICER
JAMES KRATKY subscription required
    EXECUTIVE OFFICER
JASON MCCUNE subscription required
    EXECUTIVE OFFICER
N/A BVF I GP LLC subscription required
    EXECUTIVE OFFICER
N/A BVF GP HOLDINGS LLC subscription required
    EXECUTIVE OFFICER

Elevate your investments